Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents

Brazilian Dental Journal

Volumn 23, Issue 6, 2012, Pages 716-722

  Da Silva, Wander José ^a   Gonçalves, Letícia Machado ^a   Seneviratne, Jayampath ^b   Parahitiyawa, Nipuna ^c   Samaranayake, Lakshman Perera ^b   Del Bel Cury, Altair Antoninha ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

Antifungal agents; Biofilm; Candida albicans; Denture bases

Indexed keywords

2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 5 ((PHENYLAMINO)CARBONYL) 2H TETRAZOLIUM HYDROXIDE; 2,3-BIS(2-METHOXY-4-NITRO-5-SULFOPHENYL)-5-((PHENYLAMINO)CARBONYL)-2H-TETRAZOLIUM HYDROXIDE; ANTIFUNGAL AGENT; DIAGNOSTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FLUCONAZOLE; FUNGAL POLYSACCHARIDE; NYSTATIN; POLY(METHYL METHACRYLATE); TETRAZOLIUM;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CHEMISTRY; COLORIMETRY; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; FUNGUS HYPHAE; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; METHODOLOGY; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; RANDOMIZED CONTROLLED TRIAL; SOLUBILITY; SURFACE PROPERTY; TIME;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; COLORIMETRY; CULTURE MEDIA; FLUCONAZOLE; FUNGAL POLYSACCHARIDES; HUMANS; HYPHAE; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; NYSTATIN; POLYMETHYL METHACRYLATE; SOLUBILITY; SURFACE PROPERTIES; TETRAZOLIUM SALTS; TIME FACTORS;

EID: 84872978033     PISSN: 01036440     EISSN: 18064760     Source Type: Journal    
DOI: 10.1590/S0103-64402012000600016     Document Type: Article

References (25)

1. Gendreau L, Loewy ZG. Epidemiology and etiology of denture stomatitis. J Prosthodont 2011;20:251-260.
2. Tobudic S, Kratzer C, Lassnigg A, Presterl E. Antifungal susceptibility of Candida albicans in biofilms. Mycoses 2012;55:199-204.
3. Chaffin WL. Candida albicans cell wall proteins. Microbiol Mol Biol Rev 2008;72:495-544.
4. Seneviratne CJ, Jin L, Samaranayake LP. Biofilm lifestyle of Candida: a mini review. Oral Dis 2008;14:582-590.
5. Ramage G, Rajendran R, Sherry L, Williams C. Fungal biofilm resistance. Int J Microbiol 2012;2012:528-521.
6. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001;183:5385-5394.
7. Konopka K, Dorocka-Bobkowska B, Gebremedhin S, Duzgunes N. Susceptibility of Candida biofilms to histatin 5 and fluconazole. Antonie Van Leeuwenhoek 2010;97:413-417.
8. Baillie GS, Douglas LJ. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 1998;42:1900-1905.
9. Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology 2010;98:15-25.
10. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit Rev Microbiol 2009;35:340-355.
11. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000;46:397-403.
12. Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. Antimicrob Agents Chemother 2008;52:3259-3266.
13. da Silva WJ, Seneviratne J, Samaranayake LP, Del Bel Cury AA. Bioactivity and architecture of Candida albicans biofilms developed on poly (methyl methacrylate) resin surface. J Biomed Mater Res B Appl Biomater 2010;94:149-156.
14. CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard. CLSI Document M27-A3 2008. Wayne, PA:CLSI.
15. da Silva WJ, Seneviratne J, Parahitiyawa N, Rosa EA, Samaranayake LP, Del Bel Cury AA. Improvement of XTT assay performance for studies involving Candida albicans biofilms. Braz Dent J 2008;19:364-369.
16. Tenuta LM, Ricomini Filho AP, Del Bel Cury AA, Cury JA. Effect of sucrose on the selection of mutans streptococci and lactobacilli in dental biofilm formed in situ. Caries Res 2006;40:546-549.
17. Dubois M, Gilles K, Hamilton JK, Rebers PA, Smith F. A colorimetric method for the determination of sugars. Nature 1951;28;168:167.
18. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK, et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 2000;146:2395-2407.
19. Force RW, Nahata MC. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother 1995;29:10-15.
20. Gomes PN, da Silva WJ, Pousa CC, Narvaes EA, Del Bel Cury AA. Bioactivity and cellular structure of Candida albicans and Candida glabrata biofilms grown in the presence of fluconazole. Arch Oral Biol 2011;56:1274-1281.
21. Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000;11:172-198.
22. Ellepola AN, Samaranayake LP. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. Oral Dis 1998;4:260-267.
23. Nett JE, Sanchez H, Cain MT, Andes DR. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis 2010;202:171-175.
24. Mores AU, Souza RD, Cavalca L, de Paula e Carvalho A, Gursky LC, Rosa RT, et al. Enhancement of secretory aspartyl protease production in biofilms of Candida albicans exposed to subinhibitory concentrations of fluconazole. Mycoses 2011;54:195-201.
25. Goncalves LM, Del Bel Cury AA, Sartoratto A, Garcia Rehder VL, Silva WJ. Effects of undecylenic acid released from denture liner on Candida biofilms. J Dent Res 2012;91:985-989.